Evidence map›Paper›PMID 41367637›Full record

ReviewIJID regions2025

Two decades of filariasis in India: Insights into prevalence, diagnostic challenges, and strategies for elimination by 2027.

Nandini Singh, Loick Pradel Kojom Foko, Jyoti Chhibber-Goel, Amit Sharma

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Geographical Distribution and Molecular Characterization ofAnimals : an open access journal from MDPI · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nandini SinghMolecular Medicine Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Loick Pradel Kojom FokoMolecular Medicine Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Jyoti Chhibber-GoelMolecular Medicine Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Amit SharmaMolecular Medicine Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphatic filariasis (LF) remains endemic in India, with the National Centre for Vector Borne Disease Control targeting elimination by 2027 through mass drug administration and other control tools. We reviewed 157 studies on filariasis in India (2001-2023) via PubMed, Embase, and Scopus databases. We did futher screening using Covidence and Cochrane's tools and analyzed data using GraphPad Prism and R. From 1,488,432 examined subjects (1,486,508 humans and 1924 canines), 22,938 humans were positive for LF, 26 were confirmed cases for human dirofilariasis, and 228 canines had filarial infections. Puducherry showed the highest LF prevalence (∼43%) while Kerala reported significant canine dirofilariasis (∼22%). Atypical symptoms (e.g., breast filariasis) and diagnostic gaps (e.g., lack of filaria-specific tests) complicated management, with coinfections (e.g., with

Indexed as

Brugia malayiDirofilaria repensIndiaLymphatic filariasisMass drug administrationWuchereria bancrofti

Identifiers

PMID41367637
PMCPMC12685553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.